An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children

Huda, Tanvir; Nair, Harish; Theodoratou, Evropi; Zgaga, Lina; Fattom, Ali; Arifeen, Shams El; Rubens, Craig; Campbell, Harry; Rudan, Igor
January 2011
BMC Public Health;2011 Supplement 3, Vol. 11 Issue Suppl 3, p1
Academic Journal
Background: Staphylococcus aureus is a commensal of human skin and nares. It is also one of the leading nosocomial pathogens in both developed and developing countries and is responsible for a wide range of life threatening infections, especially in patients who are immunocompromised, post-surgery, undergoing haemodialysis and those who are treated with catheters and ventilators. Over the past two decades, the incidence of nosocomial staphylococcal infections has increased dramatically. Currently there are at least seven vaccine and immunotherapy candidates against S. aureus in the developmental phase targeting both active and passive immunization. Methods: We used a modified CHNRI methodology for setting priorities in health research investments. This was done in two stages. In Stage I, we systematically reviewed the literature related to emerging vaccines against Staphylococcus aureus relevant to several criteria of interest: answerability; cost of development, production and implementation; efficacy and effectiveness; deliverability, affordability and sustainability; maximum potential impact on disease burden reduction; acceptability to the end users and health workers; and effect on equity. In Stage II, we conducted an expert opinion exercise by inviting 20 experts (leading basic scientists, international public health researchers, international policy makers and representatives of pharmaceutical companies) to participate. The policy makers and industry representatives accepted our invitation on the condition of anonymity, due to sensitive nature of their involvement in such exercises. They answered questions from CHNRI framework and their "collective optimism" towards each criterion was documented on a scale from 0 to 100%. Results: The panel of experts expressed low levels of optimism (score around or below 50%) on the criteria of answerability, efficacy, maximum disease burden reduction potential, low cost of production, low cost of implementation and affordability; moderate levels of optimism (scores around 60 to 80%) that these vaccines could be developed at a low cost, and thus on the deliverability, sustainability and impact on equity; and high levels of optimism (scores above 80%) regarding acceptable of such a product to both the end-users and health workers. While assessing the candidates for passive immunization against S.aureus, the experts were poorly optimistic regarding low production cost, low implementation cost, efficacy, deliverability, sustainability, affordability and equity; moderately optimistic regarding answerability and acceptability to health workers and end-users. They were of the opinion that these interventions would have only a modest impact (3 to 5%) on the burden of childhood pneumonia. Conclusion: In order to provide an effective vaccine against S. aureus, a number of unresolved issues in vaccine development relating to optimal antigenic target identification, criteria for acceptable efficacy, identification of target population, commercial development limitations, optimal timing of immunization strategy, storage, cold chain requirements and cost need to be addressed properly. There is still a great deal unknown about the complex interaction between S. aureus and the human host. However, given the nature of S. aureus and the lessons learned from the recent failure of two emerging vaccines, it is clear that a multi-component vaccine is essential. Combating only one virulence factor is not sufficient in the human host but finding the right combination of factors will be very challenging.


Related Articles

  • Analysis of Virulence Genes Among Methicillin Resistant Staphylococcus aureus (MRSA) Strains. Hoseini Alfatemi, Seyedeh Mahsan; Motamedifar, Mohammad; Hadi, Nahal; Ebrahim Saraie, Hadi Sedigh // Jundishapur Journal of Microbiology;Jun2014, Vol. 7 Issue 6, p1 

    Background: Staphylococcus aureus is amongst major human pathogens both in hospitals and the community. This bacterium is an opportunistic pathogen responsible for a large number of self-limiting and even life-threatening diseases in humans. Methicillin resistant S. aureus (MRSA) strains are...

  • Development of a vaccine against Staphylococcus aureus. Spellberg, Brad; Daum, Robert // Seminars in Immunopathology;Jun2012, Vol. 34 Issue 2, p335 

    A vaccine to prevent infections caused by Staphylococcus aureus would have a tremendously beneficial impact on public health. In contrast to typical encapsulated bacterial pathogens, such as Streptococcus pneumoniae, H. influenzae, and Neisseria meningitides, the capsule of S. aureus is not...

  • Pneumonia Caused by Staphylococcus aureus. Haessler, Sarah D.; Brown, Richard B. // Current Respiratory Medicine Reviews;2009, Vol. 5 Issue 1, p62 

    Staphylococcus aureus is a common human pathogen, and over the past 90 years has been increasingly recognized as an important cause of pneumonia. The epidemiology of staphylococcal pneumonia has changed over this time period, and S. aureus is now a frequent cause of both community-acquired and...

  • Nosocomial Hazards of Doctor's Mobile Phones in Hospitals. Tambekar, D. H.; Gulhane, P. B.; Dahikar, S. G.; Dudhane, M. N. // Journal of Medical Sciences;2008, Vol. 8 Issue 1, p73 

    A microbiological analysis of 75 doctor's mobile phones was carried out in Amravati city. A total of 90 bacterial pathogens were isolated, Staphylococcus aureus 18 (20%) was prominent followed by Micrococcus luteus 16 (18%), Pseudomonas aeruginosa 14 (15%), Proteus mirabilis 10 (11%),...

  • Molecular Typing of Hospital-Acquired Staphylococcus aureus Isolated from Isfahan, Iran. Havaei, Seyed Asghar; Ghanbari, Fahimeh; Rastegari, Ali Asghar; Azimian, Amir; Khademi, Farzad; Hosseini, Nafiseh; Namvar, Amirmorteza Ebrahimzadeh; Vaez, Hamid; Havaei, Seyed Mehdi; Shahin, Mojtaba // ISRN Otolaryngology;2014, p1 

    Background. Staphylococcus aureus (S. aureus) is one of the most common pathogens that cause hospital- and community-acquired infections in the world. The use of molecular typing methods is essential for determining the origin of the strains, their clonal relations, and also in epidemiological...

  • Evolving Resistance Among Gram-positive Pathogens. Rodvold, Keith A. // Clinical Infectious Diseases;2015 Supplement 2, Vol. 61, pS48 

    Antimicrobial therapy is a key component of modern medical practice and a cornerstone for the development of complex clinical interventions in critically ill patients. Unfortunately, the increasing problem of antimicrobial resistance is now recognized as a major public health threat jeopardizing...

  • Decline in Invasive MRSA Infection. Perencevich, Eli N.; Diekema, Daniel J. // JAMA: Journal of the American Medical Association;8/11/2010, Vol. 304 Issue 6, p687 

    The authors examine the relevance of a study on health care-associated invasive methicillin-resistant Staphylococcus aureus (MRSA) infections in the U.S. from 2005 to 2008 for interpretation of data on recent trends. They present a background of the emergence of MRSA as a community-associated...

  • Superbugs winning infection war.  // Australian Nursing Journal;Oct2005, Vol. 13 Issue 4, p7 

    Reports on the failure of health authorities in Australia to provide adequate infection control measures to prevent the spread of superbugs in hospitals according to the Royal Australasian College of Surgeons. Number of deaths linked to methicillin-resistant Staphylococcus aureus recorded in...

  • HOW TO STAY ON THE RIGHT SIDE OF THE INFECTION CONTROL CODE. Harrison, Sarah // Nursing Standard;6/1/2005, Vol. 19 Issue 38, p14 

    Discusses proposed British Department of Health rules to address the problem of nurses who spread methicillin-resistant Staphylococcus aureus to their patients. High incidence of disease spread originating from hospital staff; Disease background; Outline of the proposed rules.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics